Dr Marek Tyl

Executive Chairman & Founder

Marek is a scientist, manager and a technology commercialisation strategist. He completed his PhD at the Department of Biochemistry, University of Cambridge working with Professor Ernest Laue on structural aspects of chromatin assembly. His research interests are focused on epigenetics in stem cell and cancer biology, drug discovery and the development of biological tools for epigenetic therapy. He was a Post-doctoral Research Fellow at Imperial College London working on biochemical characterisation of novel chromatin-associated factors and their role in cancer.

He has extensive experience working on technology strategy, landscaping and due-diligence projects for large and mid-size pharmaceutical companies. He has over 8 years of experience in R&D in the areas of protein biochemistry and molecular biology and has advised proof of concept level biotechnology startups. He is the founder and CEO of the Innovation Forum a leading global network of early-stage innovative companies and founder of Cambridge Squared - a technology scouting & strategy consultancy.

Other team Members

Aylin Luck

View profile

Kieran Murphy

View profile

Dr Ajoeb Baridi

Deputy CEO, Innovation Forum

View profile

Marios Poullas

Director of Global Operations

View profile

Dr Bauke Anninga

COO, Innovation Forum

View profile
We use cookies to ensure that we give you the best tailored experience on our website based on your preferences. By continuing to use our services, you are giving us your consent to use cookies. Learn more here.